Remote Strategic Account Liaison: Rare Neurology

Otsuka America Pharmaceutical Inc.; Honolulu (HI); Remote; USD 158,000 - 252,000; Full time

Job summary

Otsuka America Pharmaceutical, Inc. seeks a field-based Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise.

You will communicate complex clinical data and treatment pathways to ALS Centers of Excellence, health care providers, and key stakeholders. The role requires educating on disease states, screening pathways, and patient support programs, while building durable relationships with HCPs and KOLs.

Qualifications

• Experience in understanding complex disease states and articulating complex clinical data.
• Educate on disease state awareness, screening and diagnostic pathways, and urgency to treat patients.
• Identify and maintain relationships with HCPs and Key Opinion Leaders as credible resources.
• Create positive prescribing experiences through clear articulation of access and patient support programs.
• Participate in conferences and scientific meetings to educate on rare neurology diseases and treatments.

Responsibilities

• Educate on screening and diagnostic pathways and instill urgency to treat appropriate patients.
• Develop and maintain relationships with HCPs and KOLs as credible resources.
• Articulate access and patient support programs to enable prescribing.
• Engage in conferences to educate on rare neurology diseases and treatments.
• Collaborate with cross-functional partners to align on regional strategy and execution.

Skills

Clinical acumen

HCP engagement

KOL engagement

Market access

Strategic account planning

Cross-functional collaboration

Education

Bachelor's Degree

Job description

Otsuka America Pharmaceutical, Inc. seeks a field-based Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise.

You will communicate complex clinical data and treatment pathways to ALS Centers of Excellence, health care providers, and key stakeholders. The role requires educating on disease states, screening pathways, and patient support programs, while building durable relationships with HCPs and KOLs.